Scot Shepard

Scot Shepard is from Chapel Hill, NC. Scot works in the following industries: "Biotechnology Research". Scot is currently VP, CMC Development at Icosavax, Inc.. In Scot's previous role as a Vice President, Global Technical Development at Seqirus, Scot worked in Raleigh-Durham, North Carolina Area until Feb 2020. Prior to joining Seqirus, Scot was a Senior Director, BioProcess Innovation at Takeda Vaccines and held the position of Senior Director, BioProcess Innovation at Raleigh-Durham, North Carolina Area. Prior to that, Scot was a Principal Engineer, Process Development at Amgen, based in Colorado from Nov 2011 to Jun 2013. Scot started working as Senior Director, Process Development at Biolex in Research Triangle Park, NC in Oct 2006. From Mar 1998 to Oct 2006, Scot was Director, Cell Culture and Fermentation Development at Diosynth Biotechnologies, based in Raleigh-Durham, North Carolina Area. Prior to that, Scot was a Process Development Scientist at Bayer, based in Clayton, NC from Jan 1996 to Mar 1998. Scot started working as Process Development Associate at North American Biologicals in Miami/Fort Lauderdale Area in Jan 1994.